VIVES
Venture capital · Belgium · Europe
VIVES is an investment fund initiated by UCLouvain that invests in companies, including spin-offs from university research. It is a multisectoral fund that invests in projects with positive societal impact.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsuniversity spin-offsbiotechlife sciencesimpactmultisectoral
Your fit with VIVES
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVIVES lists 22 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (52%), AI & Machine Learning (24%) and Industrial & Manufacturing (10%). 65% of its companies are based in Belgium. It invests most often alongside Invest.BW, Noshaq and Agri Investment Fund.
Counts come from funding rounds that name VIVES, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not VIVES' whole history. Rounds on record name 3 companies; its own site lists 22. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundVIVES does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 55th | 22 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 75th | 9% of companies confirmed by a round |
| Sector focus | 85th | 52% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Invest.BW | 6 |
| Noshaq | 5 |
| Agri Investment Fund | 3 |
| Kurma Partners | 3 |
| V-Bio Ventures | 3 |
| Agoranov | 2 |
| Fund+ | 2 |
| Sanofi Ventures | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2195%
- No longer answers00%
- Points to another company15%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 52% | 15% |
| AI & Machine Learning | 24% | 18% |
| Industrial & Manufacturing | 10% | 7% |
| Consumer | 3% | 3% |
| Media & Entertainment | 3% | 4% |
| Gaming | 3% | 1% |
| Fintech | 3% | 12% |
Co-investor network
who it backs companies with, and who they back togetherCompare VIVES head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with VIVES| Date | Company | Stage |
|---|---|---|
| 21 Sept 2026 | Debt | |
| 25 Sept 2025 | Round | |
| 10 Jul 2025 | Series B |
Round details for VIVES
Amounts, full round histories and every co-investor in VIVES' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
22 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| 3D-Side supports healthcare professionals with AI-powered 3D preoperative planning and patient-specific medical devices. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| ATB Therapeutics develops novel therapeutic solutions for patients with cancer and auto-immune disease using antibody payload technology. | Healthcare & Biotech | Portfolio page | ||
| Axinesis evaluates the maturity of medical devices and defines the necessary work to advance them with their clients. | Healthcare & Biotech | Portfolio page | ||
| BiocSol develops biopesticides based on defined natural substances produced by beneficial microorganisms | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Bionyra Pharma is a clinical-stage biopharmaceutical company developing antibody therapies for immune-mediated inflammatory diseases such as atopic dermatitis and inflammatory bowel disease. | Healthcare & Biotech | Portfolio page | ||
| Botalys develops and supplies premium botanical ingredients through biomimetic indoor farming | AI & Machine LearningHealthcare & Biotech | Portfolio page | ||
| E-PEAS designs and manufactures energy harvesting power management integrated circuits and other related products | Industrial & ManufacturingConsumer | Portfolio page | ||
| Eligo Bioscience edits the microbiome gene repertoire in vivo | Healthcare & Biotech | Portfolio page | ||
| ExeVir Bio develops novel antibody therapies to prevent and treat infectious diseases. | Healthcare & Biotech | Portfolio page | ||
| Generare develops new medicines by exploring and utilizing microbial chemistry | Healthcare & Biotech | Portfolio page | ||
| Sunrise develops and sells a medical device for diagnosing sleep apnea at home | Healthcare & Biotech | Portfolio page | ||
Media & EntertainmentGaming | Portfolio page | |||
| LMO delivers mission-proven solutions for chemical, cold gas, and electric propulsion, enabling precise and reliable spacecraft maneuvering. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Novadip Biosciences develops regenerative tissue products for bone and tissue repair | Healthcare & Biotech | Sept 2026Debt | Page + round | |
| Nuclidium develops next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer | Healthcare & Biotech | Jul 2025Series B | Page + round | |
| The company provides telecommunications solutions, including 4G, 5G, and hybrid internet access | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| The company develops and sells supplements containing Akkermansia muciniphila for gut health | Healthcare & Biotech | Portfolio page | ||
| Sunrise develops and provides a sleep apnea test using mandibular jaw movements technology. | Healthcare & Biotech | Sept 2025Round | Funding round | |
| Viridaxis is a company specialized in the mass production of parasitoids to control aphids in a natural way | AI & Machine LearningAI & Machine Learning | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- vivesfund.com
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 10 Jul 2025
- Companies checked
- 22
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get VIVES' profile as data
Pull VIVES' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vivesfund.com
# also
GET /v1/firms/vivesfund.com/portfolio
GET /v1/firms/vivesfund.com/coinvestors
GET /v1/firms/vivesfund.com/news